Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Terbinafine hydrochloride
Drug ID BADD_D02161
Description Terbinafine hydrochloride (Lamisil) is a synthetic allylamine antifungal.[L9065,L9068] It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.[A1279] Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.[A1279,A1281,L9068] Terbinafine hydrochloride was granted FDA approval on 30 December 1992.[L9064]
Indications and Usage For the treatment of dermatophyte infections of the toenail or fingernail caused by susceptible fungi. Also for the treatment of tinea capitis (scalp ringworm) and tinea corporis (body ringworm) or tinea cruris (jock itch).
Marketing Status OTC; Discontinued; Prescription
ATC Code D01AE15; D01BA02
DrugBank ID DB00857
KEGG ID D02219
MeSH ID D000077291
PubChem ID 5282481
TTD Drug ID D01AYJ
NDC Product Code 70159-006; 50090-5810; 60429-222; 55700-344; 24385-524; 14501-0012; 71205-492; 11822-0080; 69037-0049; 41250-080; 49035-080; 66039-859; 73309-177; 38779-3253; 61047-120; 71205-061; 48087-0079; 63629-8137; 50066-208; 68788-7450; 66039-817; 52562-600; 41520-080; 0067-6297; 63187-792; 68071-1640; 55111-250; 50066-080; 70518-2941; 68016-080; 71335-0257; 0363-2083; 16714-795; 50090-1278; 72969-071; 51991-526; 59779-080; 71205-127; 64679-743; 42043-410; 59349-0007; 50090-3575; 11673-080; 68071-4578; 55111-024; 68554-0002; 50090-1048; 51655-364; 71335-0918; 0067-6296; 51769-121; 68788-9814; 49386-007; 51672-2140; 51672-2083; 52286-0007; 37808-080; 51927-4856; 70000-0338; 68788-7187; 71335-1836; 51672-2080; 65862-079; 65862-364; 0363-2080; 59779-523; 49452-7627; 49348-790; 68071-2426; 45201-526; 30142-080; 38779-2481; 70518-0553; 68071-4500; 53069-0530; 63629-1993; 43353-893; 68071-4873; 0067-3999; 50090-3654; 67405-500; 43063-598; 53104-7577; 69452-351; 53002-0550; 70518-1743; 62991-3085; 43063-906; 0067-8114; 0067-8100; 68071-4712; 36800-080; 66219-0001; 68071-2579; 71335-1124; 61919-451; 63187-111
Synonyms Terbinafine | Terbinafine, (Z)-isomer | Terbinafine, (Z)- | Lamisil | (E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride | TDT-067 | TDT 067 | TDT067 | DA 5505 | SF 86-327 | SF 86 327 | SF 86327 | SF-86-327 | SF86327 | Terbinafine Hydrochloride
Chemical Information
Molecular Formula C21H26ClN
CAS Registry Number 78628-80-5
SMILES CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Ageusia17.02.07.001; 07.14.03.003--Not Available
Agranulocytosis01.02.03.001--Not Available
Alopecia23.02.02.001--
Anaemia01.03.02.001--
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anosmia22.04.03.006; 17.04.04.001--
Anxiety19.06.02.002--
Arthralgia15.01.02.001--
Blood creatine phosphokinase increased13.04.01.001--
Cholestasis09.01.01.001--Not Available
Depression19.15.01.001--
Dermatitis bullous23.03.01.002--
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Erythema multiforme23.03.01.003; 10.01.03.015--
Fatigue08.01.01.002--
Flatulence07.01.04.002--
Headache17.14.01.001--
Hepatic failure09.01.03.002--
Hepatitis09.01.07.004--Not Available
Hypersensitivity10.01.03.003--
Hypoaesthesia17.02.06.023--Not Available
Influenza like illness08.01.03.010--
Malaise08.01.01.003--
Myalgia15.05.02.001--
Nausea07.01.07.001--
The 1th Page    1 2 3    Next   Last    Total 3 Pages